10% Owner Charles Cheever Buys $114.8K of CVSI Stock at $0.02
CVSI sits 31% above its 52-week low of $0.015 on light trading volume (0.1× avg).
Summary
10% owner Charles Cheever bought 5.74M shares of CVSI for $114.8K at $0.02/share across 10 open-market trades in July-August 2026, raising his stake to 26.65M shares.
Key Events · Ownership and Investor Activity · CVSI
-
10% Owner Buys 5.74M Shares
Charles E. Cheever III acquired 5,740,816 shares for $114,816.32 across 10 open-market purchases at $0.02 per share between July 16 and August 7, 2026.
-
Stake Rises to 26.65M Shares
Post-transaction direct holdings reached 26,648,711 shares, a meaningful increase for a 10% owner.
-
Buying Precedes Going Concern Warning
Purchases occurred just weeks before the Q2 10-Q reiterated a going concern warning with only $266K cash and a net loss of $775K.
-
Open-Market Conviction
All transactions were Code P open-market purchases, not option exercises or grants, indicating real capital deployment.
Analysis · CVSI · Life Sciences
A 10% owner's open-market buying spree often signals conviction, and that's exactly what Charles E. Cheever III demonstrated by acquiring 5.74 million shares of CV Sciences for $114,816 across ten transactions between July 16 and August 7, 2026, at $0.02 per share. The timing is particularly striking: just weeks later, the company's Q2 10-Q reiterated a going concern warning with only $266K in cash and a widening net loss. While the dollar amount is modest in absolute terms, a large holder putting real money in at these levels suggests confidence in the company's survival or a strategic position. The purchases lifted his direct holdings to 26.65 million shares, a meaningful increase in his stake.
How filings like this one have moved
In the 30 days to Sep 9, 2026, 30% of the 1972 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.02%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CVSI was trading at $0.02 on OTC in the Life Sciences sector, with a market capitalization of approximately $4.3M. The 52-week trading range was $0.01 to $0.10. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.